Phase 3 trial of eribulin versus dacarbazine for the treatment of advanced liposarcoma or leiomyosarcoma | Prof Patrick Schöffski at ASCO 2015
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Patrick Schöffski, MD, of University Hospitals Leuven, Leuven, Belgium, discusses the results of a randomised, open-label, mult...
Author: EMJ
Added: 07/02/2015
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts